Conversely, eIF4A2 is present at high levels in resting cells and low levels of eIF4A2 has been associated with poor outcome for patients with breast and non-small-cell lung cancers [52,53]. The gene discussed is EIF4A2; the disease is non-small cell lung carcinoma.